Patent Oppositions in medical and personal care products industry

Explore the competitive field of medical and personal care products where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in medical and personal care products technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the medical and personal care products industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the medical and personal care products industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Aug 6, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)BRISTOL MYERS SQUIBBJul 29, 2026STORZ
Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)BRISTOL MYERS SQUIBBJul 28, 2026PAJARO
Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)BRISTOL MYERS SQUIBBJul 27, 2026GREINER
Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)BRISTOL MYERS SQUIBBJul 17, 2026POHLMAN
Methods Of Treating Hfpef Employing Dapagliflozin And Compositions Comprising The SameASTRAZENECAJul 15, 2026TEVA PHARMACEUTICALS
Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)BRISTOL MYERS SQUIBBJul 13, 2026MANZER
Formulations Of Ag10EIDOS THERAPEUTICSJun 30, 2026RIECHELMANN
Methods For Production Of Capsular Polysaccharide Protein Conjugates From Streptococcus Pneumoniae Serotype 19FMERCK SHARP & DOHMEJun 24, 2026SK BIOSCIENCE
Formulations Of Ag10EIDOS THERAPEUTICSJun 23, 2026DR SCHON
Pharmaceutical Compositions Comprising CabotegravirVIIV HEALTHCAREJun 19, 2026ELKINGTON AND FIFE

To stay ahead in the competitive medical and personal care products industry, companies are constantly innovating. Here are the top patents facing oppositions in the medical and personal care products industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Aug 6, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Oct 12, 2022S1P Receptor Modulators For Treating Multiple SclerosisNOVARTIS26
Apr 14, 2021Methods And Compositions For Treating CancerCOUGAR BIOTECHNOLOGY24
Nov 6, 2024Dosing Regimen Associated With Long Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICA23
Oct 23, 2024New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTIS20
Jan 17, 2024Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIM19
Oct 11, 2023New UseNOVARTIS19
Aug 6, 2025Use Of Long-Acting Glp-1 PeptidesNOVO NORDISK18
Mar 8, 2023Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTIS18
Jan 16, 2019(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions ThereofAMGEN EUROPE17
Mar 10, 2021Novel Antitumoral Use Of CabazitaxelAVENTIS PHARMA15